Markets:

Overview

News

Currencies

International

Treasuries

Precision BioSciences, Inc. - Common Stock (NQ:DTIL)

4.010 -0.020 (-0.50%)

Streaming Delayed Price Updated: 11:19 AM EST, Jan 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Precision BioSciences, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Preview: Precision BioSciences's Earnings ↗

May 06, 2022

Precision BioSciences (NASDAQ:DTIL) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Precision BioSciences to Present Preclinical In Vivo Gene Editing Research at Upcoming American Society of Gene & Cell Therapy 25th Annual Meeting

May 02, 2022

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences to Report First Quarter 2022 Financial Results on May 9, 2022

May 02, 2022

From Precision BioSciences, Inc.

Via Business Wire

66 Biggest Movers From Yesterday ↗

March 23, 2022

Gainers JX Luxventure Limited (NASDAQ: LLL) shares jumped 119.5% to settle at $4.39 on Tuesday after the company announced it signed a $60 million sales agreement. Forge Global...

Via Benzinga

43 Stocks Moving In Tuesday's Mid-Day Session ↗

March 22, 2022

Gainers Forge Global Holdings Inc. (NYSE: FRGE) shares jumped 67.7% to $16.95. True Global Ventures’ portfolio company Forge Global Holdings completed its business...

Via Benzinga

Lannett And 4 Other Penny Stocks Bought By Insiders ↗

March 22, 2022

US stock futures traded higher this morning on Tuesday. Investors, meanwhile, focused on some notable insider trades When insiders purchase or sell shares, it indicates their confidence or concern...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

March 16, 2022

On Wednesday, 90 companies set new 52-week lows. Areas of Significance In Today's 52-Week Lows: The company with the largest market cap to set a new 52-week low was...

Via Benzinga

Looking Into Precision BioSciences's Return On Capital Employed ↗

March 16, 2022

Precision BioSciences (NASDAQ:DTIL) brought in sales totaling $6.34 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 97.62%, resulting in...

Via Benzinga

68 Biggest Movers From Yesterday ↗

March 16, 2022

Gainers Sonim Technologies, Inc. (NASDAQ: SONM) shares jumped 103.3% to settle at $1.22 on Tuesday after the company announced its XP8 smartphone has integrated with the Walkie...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 15, 2022

Gainers Incannex Healthcare (NASDAQ:IXHL) stock rose 164.2% to $60.5 during Tuesday's regular session. Incannex Healthcare's stock is trading at a volume of 664.5K...

Via Benzinga

The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial ↗

March 15, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Recap: Precision BioSciences Q4 Earnings ↗

March 15, 2022

Precision BioSciences (NASDAQ:DTIL) reported its Q4 earnings results on Tuesday, March 15, 2022 at 07:00 AM. Here's what investors need to know about the announcement....

Via Benzinga

Precision BioSciences Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Update

March 15, 2022

From Precision BioSciences, Inc.

Via Business Wire

Earnings Scheduled For March 15, 2022 ↗

March 15, 2022

Companies Reporting Before The Bell • IDEAYA Biosciences (NASDAQ:IDYA) is likely to report quarterly loss at $0.31 per share on revenue of $8.98 million. • Citi...

Via Benzinga

Preview: Precision BioSciences's Earnings ↗

March 14, 2022

Precision BioSciences (NASDAQ:DTIL) is set to give its latest quarterly earnings report on Tuesday, 2022-03-15. Here's what investors need to know before the announcement....

Via Benzinga

Precision BioSciences to Present at the 40th Annual J.P. Morgan Health Care Conference

January 04, 2022

From Precision BioSciences, Inc.

Via Business Wire

The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings ↗

March 13, 2022

Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments...

Via Benzinga

Precision BioSciences Completes Spin-Out of Elo Life Systems

December 21, 2021

From Precision BioSciences, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Wednesday ↗

January 05, 2022

Before 10 am on Wednesday, 99 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: Sea (NYSE:SE) was the largest firm by market cap to set a...

Via Benzinga

Precision BioSciences Reports Clinical Program Updates for Its Allogeneic CAR T Pipeline

December 11, 2021

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences to Host Virtual Webcast and Conference Call to Review Interim Phase 1/2a PBCAR0191 CAR T Data and Provide CAR T Program Updates on Saturday, December 11, 2021

December 06, 2021

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences to Present Preclinical Gene Editing Data on its ARCUS-Based Chronic Hepatitis B Program at the HEP DART 2021 Conference

December 03, 2021

From Precision BioSciences, Inc.

Via Business Wire

The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More ↗

December 06, 2021

The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 18, 2021

Gainers NeuroOne Medical Tech (NASDAQ:NMTC...

Via Benzinga

Precision BioSciences Earnings Perspective: Return On Capital Employed ↗

November 11, 2021

Benzinga Pro data, Precision BioSciences (NASDAQ:DTIL) reported Q3 sales of $24.04 million. Earnings fell to a loss of $11.27 million, resulting in a 152.09% decrease from last...

Via Benzinga

Precision BioSciences Reports Third Quarter 2021 Financial Results and Provides Business Update

November 10, 2021

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences Earnings Preview ↗

November 09, 2021

Precision BioSciences (NASDAQ:DTIL) is set to give its latest quarterly earnings report on Wednesday, 2021-11-10. Here's what investors need to know before the announcement....

Via Benzinga

Precision BioSciences to Highlight Capabilities of ARCUS Gene Editing for Allogeneic CAR T Cell Immunotherapies at The Society for Immunotherapy of Cancer 36th Annual Meeting

November 09, 2021

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences Appoints Sam Wadsworth, Ph.D. and Shari Lisa Piré, J.D. to Board of Directors

November 08, 2021

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences Announces Two Oral Presentations Highlighting Updated Interim Data from Lead PBCAR0191 CAR T Immunotherapy for Relapsed and Refractory B-cell Malignancies at the 63rd Annual Meeting of the American Society of Hematology

November 04, 2021

From Precision BioSciences, Inc.

Via Business Wire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.